Plain Language Summary

What is it about? Valuation studies are essential for determining the value of health states, particularly in low- and middle-income countries (LMICs), where resources are limited. These studies are crucial for health technology assessments, which help governments make informed healthcare decisions. The researchers focused on understanding how these studies manage resource challenges in less affluent countries. The study fills a gap by examining current adaptations in methodology that aim to make these studies more feasible in resource-constrained settings. The paper suggests several innovative approaches to overcome these challenges, contributing valuable insights into conducting valuation studies in such environments.

How was the research conducted? The study is based on a scoping review, which involves surveying existing research to identify key themes and gaps. Researchers applied this methodology by searching databases like MEDLINE and EMBASE for valuation studies conducted in LMICs. They focused on studies that used specific techniques to gather data on health state preferences. The researchers reviewed 36 studies from various countries, focusing on the methods used and adaptations made to address resource limitations. This approach was chosen to provide a comprehensive overview of current practices and innovations in the field.

What were the results? The study found that valuation studies are increasing in LMICs, with new methods emerging to reduce resource demands. Notably, "lite" protocols and portable tools were among the adaptations identified. An important finding was the use of methods to include illiterate participants and those speaking different languages, although this remains an area needing improvement. Surprisingly, despite these innovations, resource constraints continue to limit the implementation of valuation studies in poorer countries.

Why are the results important? For health technology assessment agencies, these findings highlight the need for innovative methods that reduce costs and enhance inclusivity. Practically, these adaptations can lead to more accurate and equitable health assessments, which can improve healthcare decision making. Patients and healthcare providers benefit from these findings as they can lead to better resource allocation and health outcomes. In the long term, these innovations could make valuation studies more accessible and widespread, promoting better health policy decisions globally.

What are the strengths and weaknesses of this study? The study's strength lies in its comprehensive review of a wide range of valuation studies, offering valuable insights into current methodologies and innovations. However, a limitation is the lack of detailed descriptions in some of the reviewed studies, which may affect the depth of the analysis. Future research could focus on validating these new methodologies in diverse settings to ensure their effectiveness and scalability, further expanding the knowledge base in this critical area.

Note: This content was created with assistance from artificial intelligence (AI) and has been reviewed and edited by ISPOR staff. For more information or for inquiries on ISPOR’s AI policy, click here or contact us at info@ispor.org.